Sustained-release chemotherapy gives new option for frail patients with invasive bladder cancer

For patients with advanced bladder cancer who are medically unfit for standard treatment, a new intravesical (inside the bladder) chemotherapy delivery system called TAR-200 is safe and shows initial evidence of effectiveness, reports a study in The Journal of Urology.

Leave A Comment

Your email address will not be published. Required fields are marked *